Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The genus Lactobacillus is a taxonomically complex and is composed of over 170 species that cannot be easily differentiated phenotypically and often require molecular identification. Although they are part of the normal human gastrointestinal and vaginal flora, they can also be occasional human pathogens. They are extensively used in a variety of commercial products including probiotics. Their antimicrobial susceptibilities are poorly defined in part because of their taxonomic complexity and are compounded by the different methods recommended by Clinical Laboratory Standards Institute and International Dairy Foundation. Their use as probiotics for prevention of Clostridium difficile infection is prevalent among consumers worldwide but raises the question of will the use of any concurrent antibiotic effect their ability to survive. Lactobacillus species are generally acid resistant and are able to survive ingestion. They are generally resistant to metronidazole, aminoglycosides and ciprofloxacin with L. acidophilus being susceptible to penicillin and vancomycin, whereas L. rhamnosus and L. casei are resistant to metronidazole and vancomycin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, some Lactobacillus spp. are intrinsically resistant to vancomycin and aminoglycosides, while other glycopeptides will have varying activity.”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [1]
In the citing paper
“They noted that it is impossible to predict or make specific recommendations about individual species or strains.”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [1]
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Jorgensen, J. H., & Clinical (2006) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,047
Antibiotic resistance in probiotic bacteria
Gueimonde, M., Sánchez, B., G. de los Reyes-Gavilán, C., & Margolles, A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00202 · Cited by 691 · cited 5×
“Gueimonde et al [31] reported that although often susceptible to macrolides, chromosomal mutations in lactobacilli such as in L. rhamnosus can reduce the affinity of erythromycin for the ribosome.”
BackgroundInfluentialLactic acid bacteria as probiotics.
Ljungh, Å., & Wadström, T. (2006) · PubMed · Cited by 542
Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases
Cannon, J. P., Lee, T. A., Bolanos, J. T., & Danziger, L. H. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1253-y · Cited by 478 · cited 1×
“casei [20] L.”
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 2×
“In 2004 Salminen, et al [30] reviewed 89 patients between 1990 and 2000 with Lactobacillus bacteremia, including L.”
BackgroundLactic acid bacteria and human clinical infection
Aguirre, M., & Collins, M. D. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb02753.x · Cited by 425 · cited 2×
“They utilize carbohydrates fermentatively and produce lactic acid as a major endproduct [1].”
BackgroundLiévin-Le Moal, V., & Servin, A. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00080-13 · Cited by 354 · cited 3×
“Lactobacillus acidophilus occurs naturally in the human and animal gastrointestinal tract and mouth [4].”
BackgroundNawaz, M., Wang, J., Zhou, A., Ma, C., Wu, X., Moore, J. E., Cherie Millar, B., & Xu, J. (2011) · Current Microbiology · doi:10.1007/s00284-010-9856-2 · Cited by 281 · cited 3×
“isolates] Goldstein [38–42] Salminen [8] Nawaz [36]”
BackgroundSalminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2006) · Clinical Infectious Diseases · doi:10.1086/500214 · Cited by 218 · cited 7×
“In a 2006 follow-up study, Salminen et al [8] compared the antimicrobial therapy and susceptibilities in 85 patients between 1984 and 2000 of Lactobacillus bacteremia, including 46 L.”
BackgroundInfluentialJespers, V., Menten, J., Smet, H., Poradosú, S., Abdellati, S., Verhelst, R., Hardy, L., Buvé, A., & Crucitti, T. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-83 · Cited by 158 · cited 1×
“iners are common vaginal isolates [3].”
Vahabnezhad, E., Mochon, A. B., Wozniak, L. J., & Ziring, D. A. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318279abf0 · Cited by 156 · cited 1×
“rhamnosus [8, 12, 13] L.”
Roos, S., Engstrand, L., & Jonsson, H. (2005) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.63083-0 · Cited by 106 · cited 1×
“ultunensis have been isolated from the stomach mucosa [2].”
BackgroundGoldstein, E. J. C., Citron, D. M., Merriam, C. V., Warren, Y. A., Tyrrell, K. L., & Fernandez, H. T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1968-1971.2003 · Cited by 105 · cited 2×
“Some species of lactobacilli are intrinsically resistant to vancomycin and aminoglycosides [8, 31], whereas other glycopeptides have variable activity against different species and strains [32, 33].”
BackgroundResultSelf-citationA Retrospective Review of Cases of Anaerobic Empyema and Update of Bacteriology
Civen, R., Jousimies-Somer, H., Marina, M., Borenstein, L., Shah, H., & Finegold, S. M. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_2.s224 · Cited by 103 · cited 1×
“plantarum [16] Empyema Lactobacillus species [17, 18]”
Lactobacillus rhamnosus bacteremia: An emerging clinical entity
Gouriet, F., Million, M., Henri, M., Fournier, P.-E., & Raoult, D. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1599-5 · Cited by 93 · cited 1×
“rhamnosus [8, 12, 13] L.”
Goldstein, E. J. C., Citron, D. M., Merriam, C. V., Warren, Y. A., & Tyrrell, K. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2389-2394.2000 · Cited by 88 · cited 3×
“isolates] Goldstein [38–42] Salminen [8] Nawaz [36]”
BackgroundResultSelf-citationGoldstein, E. J. C., Citron, D. M., Tyrrell, K. L., & Merriam, C. V. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01136-13 · Cited by 82 · cited 3×
“isolates] Goldstein [38–42] Salminen [8] Nawaz [36]”
BackgroundResultSelf-citationRobin, F., Paillard, C., Marchandin, H., Demeocq, F., Bonnet, R., & Hennequin, C. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00250-10 · Cited by 71 · cited 1×
“rhamnosus [12,23] Meningitis L.”
Auclair, J., Frappier, M., & Millette, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ179 · Cited by 67 · cited 2×
“rhamnosus CLR2 (BioK+, Laval, Quebec, Canada) [4, 7].”
Goldstein, E. J. C., Citron, D. M., Merriam, C. V., Warren, Y. A., Tyrrell, K. L., & Fernandez, H. T. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00499-06 · Cited by 63 · cited 1×
“casei [34].”
Self-citationGoldstein, E. J. C., Citron, D. M., Merriam, C. V., Warren, Y. A., Tyrrell, K. L., Fernandez, H. T., & Bryskier, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.408-413.2005 · Cited by 50 · cited 1×
“Many of our previous studies [33, 37] as well as those of others [32], have reported diverse Lactobacillus species together making it impossible to make specific comments about individual species.”
ResultSelf-citationIn Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria
Citron, D. M., Tyrrell, K. L., Merriam, C. V., & Goldstein, E. J. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01788-09 · Cited by 49 · cited 3×
“isolates] Goldstein [38–42] Salminen [8] Nawaz [36]”
BackgroundResultSelf-citationLuong, M.-L., Sareyyupoglu, B., Nguyen, M. H., Silveira, F. P., Shields, R. K., Potoski, B. A., Pasculle, W. A., Clancy, C. J., & Toyoda, Y. (2010) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2010.00580.x · Cited by 46 · cited 1×
“plantarum [16] Empyema Lactobacillus species [17, 18]”
Klein, G., Zill, E., Schindler, R., & Louwers, J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.6.1781-1783.1998 · Cited by 45 · cited 1×
“rhamnosus [26] Prosthetic knee infection Lactobacillus species [27] Pyelonephritis L.”
BackgroundMaziade, P.-J., Andriessen, J. A., Pereira, P., Currie, B., & Goldstein, E. J. C. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.833501 · Cited by 40 · cited 2×
“Mazaide et al [29] reported the use of a probiotic combination of L. acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 (Bio-K+) in 31 382 patients over a 7 year period and found no episodes of Lactobacillus bacteremia.”
BackgroundSelf-citationLactobacillus paracasei endocarditis in a consumer of probiotics
Franko, B., Vaillant, M., Recule, C., Vautrin, E., Brion, J.-P., & Pavese, P. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.01.007 · Cited by 40 · cited 1×
“paracasei [22] L.”
Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic
Goldstein, B. P., Candiani, G., Arain, T. M., Romanò, G., Ciciliato, I., BERTI, M., Abbondi, M., Scotti, R., Mainini, M., & RIPAMONTI, F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1580 · Cited by 37 · cited 2×
“Some species of lactobacilli are intrinsically resistant to vancomycin and aminoglycosides [8, 31], whereas other glycopeptides have variable activity against different species and strains [32, 33].”
BackgroundResultCallaway, A., Kostrzewa, M., Willershausen, B., Schmidt, F., Thiede, B., Küpper, H., & Kneist, S. (2013) · Clinical Laboratory · doi:10.7754/clin.lab.2013.121225 · Cited by 36 · cited 1×
“plantarum [16] Empyema Lactobacillus species [17, 18]”
Simova, E. D., Beshkova, D. M., Angelov, M., & Dimitrov, Z. P. (2008) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-008-0317-x · Cited by 36 · cited 1×
“It produces bacteriocins [6], which can be bactericidal in vitro.”
BackgroundSuárez-García, I., Sánchez-García, A., Soler, L., Malmierca, E., & Gómez-Cerezo, J. (2012) · Infection · doi:10.1007/s15010-011-0182-9 · Cited by 33 · cited 1×
“jensenii [8, 10, 11] L.”
Wade, W. G., & K�n�nen, E. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch49 · Cited by 33
Endocarditis caused by Lactobacillus jensenii in an immunocompetent patient
Fradiani, P. A., Petrucca, A., Ascenzioni, F., Di Nucci, G., Teggi, A., Bilancini, S., & Cipriani, P. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.017764-0 · Cited by 30 · cited 1×
“jensenii [11, 21] L.”
Flórez, A. B., Ladero, V., Álvarez‐Martín, P., Ammor, M. S., Álvarez, M. A., & Mayo, B. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.002 · Cited by 29 · cited 1×
“Chromosomal mutations in lactobacilli have been observed also, including the single mutation in the 23S rRNA gene that reduces the affinity of erythromycin to the ribosome [35].”
BackgroundAcute acalculous cholecystitis complicated with peritonitis caused by Lactobacillus plantarum
Tena, D., Martínez, N. M., Losa, C., Fernández, C., Medina-Pascual, M. J., & Sáez-Nieto, J. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.03.018 · Cited by 28 · cited 1×
“plantarum [15] Dental abscess/caries L.”
Lactobacillus fermentum, a pathogen in documented cholecystitis
Chery, J., Dvoskin, D., Morato, F. P., & Fahoum, B. (2013) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2013.04.034 · Cited by 27
(2008) · PubMed · Cited by 25
Mayrhofer, S., Zitz, U., Birru, F. H., Gollan, D., Gołoś, A. K., Kneifel, W., & Domig, K. J. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0189 · Cited by 25
Goldstein, E. J. C., Citron, D. M., Tyrrell, K. L., & Merriam, C. V. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02580-12 · Cited by 24 · cited 3×
“isolates] Goldstein [38–42] Salminen [8] Nawaz [36]”
BackgroundResultSelf-citationNishijima, T., Teruya, K., Yanase, M., Tamori, Y., Mezaki, K., & Oka, S. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.7294 · Cited by 24 · cited 1×
“acidophilus [19] L.”
Goldstein, E. J. C., Citron, D. M., Merriam, C. V., Warren, Y. A., Tyrrell, K. L., & Fernandez, H. T. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1136-1140.2002 · Cited by 24 · cited 3×
“isolates] Goldstein [38–42] Salminen [8] Nawaz [36]”
BackgroundResultSelf-citationNeef, P. A., Polenakovik, H. M., Clarridge, J. E., Saklayen, M. G., Bogard, L., & Bernstein, J. M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2783-2784.2003 · Cited by 22
Investigation of inpatient probiotic use at an academic medical center
Simkins, J., Kaltsas, A., & Currie, B. P. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.11.010 · Cited by 19 · cited 1×
“In a 2 part study, Simkins et al [28] investigated probiotic use and bacteremia at an academic medical center.”
BackgroundIsolated Lactobacillus Chronic Prosthetic Knee Infection
Bennett, D. M., Shekhel, T. A., Radelet, M., & Miller, M. D. (2014) · Orthopedics · doi:10.3928/01477447-20131219-22 · Cited by 13 · cited 1×
“rhamnosus [26] Prosthetic knee infection Lactobacillus species [27] Pyelonephritis L.”
BackgroundPrimary peritonitis due to Lactobacillus fermentum
Greig, J., Eltringham, I. J., & Birthistle, K. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80027-3 · Cited by 9 · cited 1×
“fermentum [24] L.”
Research works printed but not linked: 1
- Clinical, Laboratory Standards I, 2012, Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard-8th edition
Cited by
Mokoena, M. P. (2017) · Molecules · doi:10.3390/molecules22081255 · Cited by 672
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview
Piqué, N., Berlanga, M., & Miñana-Galbis, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102534 · Cited by 642
McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00124 · Cited by 609
Self-citationIntestinal flora and disease mutually shape the regional immune system in the intestinal tract
Zhou, B., Yuan, Y., Zhang, S., Guo, C., Li, X., Li, G., Xiong, W., & Zeng, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00575 · Cited by 396
Thirty Years of Lactobacillus rhamnosus GG: A Review
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 381
Metadata
- Authors
- Goldstein, E. J. C., Tyrrell, K. L., & Citron, D. M.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Goldstein, Ellie J. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S98-S107
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2072888501
- Cited by
- 392
- References
- 45
- Citations by year
- 2026: 22 · 2025: 42 · 2024: 42 · 2023: 78 · 2022: 42 · 2021: 37 · 2020: 56 · 2019: 29 · 2018: 20 · 2017: 12 · 2016: 9 · 2015: 2
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Lactobacillus, bacterial taxonomy, antimicrobial susceptibility, probiotics, Clostridium difficile infection, antibiotic resistance, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus casei, metronidazole resistance, vancomycin resistance, acid resistance, gut microbiota, vaginal microbiota, human pathogens
- MeSH terms
- Anti-Bacterial Agents, Female, Food Microbiology, Humans, Lactobacillus, Lactobacillus acidophilus, Lacticaseibacillus casei, Metronidazole, Microbial Sensitivity Tests, Colony Count, Microbial, Bacteremia, Gram-Positive Bacterial Infections, Probiotics, Drug Resistance, Bacterial, Lacticaseibacillus rhamnosus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.